Search

Date 2016 Author/Creator Capdevila, Jaume

1. Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study. Issue 3 (7th January 2016)

Authors:
Caplin, Martyn E; Pavel, Marianne; Ćwikła, Jarosław B; Phan, Alexandria T; Raderer, Markus; Sedláčková, Eva; Cadiot, Guillaume; Wolin, Edward M; Capdevila, Jaume; Wall, Lucy; Rindi, Guido; Langley, Alison; Martinez, Séverine; Gomez-Panzani, Edda; Ruszniewski, Philippe
Journal:
Endocrine-related cancer
Issue:
Volume 23:Issue 3(2016)
Page Start:
191
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program. Issue 1 (December 2016)

Authors:
Sevilla, Isabel; Segura, Ángel; Capdevila, Jaume; López, Carlos; García-Carbonero, Rocío; Grande, Enrique
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗